{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:32:16Z","timestamp":1786357936478,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":100,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.lrr.2025.100509","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T20:56:08Z","timestamp":1744491368000},"page":"100509","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["AL amyloidosis with elevated peripheral blood cell counts \u2013 A frequent association with liver involvement. A single-center retrospective study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-8288","authenticated-orcid":false,"given":"Mateusz","family":"Ziarkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Szczygie\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Legatowicz-Koprowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Drozd-Soko\u0142owska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Boguradzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Jamroziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lrr.2025.100509_bib0001","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13506129.2020.1835263","article-title":"Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee","volume":"27","author":"Benson","year":"2020","journal-title":"Amyloid"},{"issue":"3","key":"10.1016\/j.lrr.2025.100509_bib0002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40265-022-01830-z","article-title":"Diagnosis and treatment of AL amyloidosis","volume":"83","author":"Palladini","year":"2023","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.lrr.2025.100509_bib0003","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic Amyloidosis recognition, prognosis, and therapy: a systematic review","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.lrr.2025.100509_bib0004","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"15","key":"10.1016\/j.lrr.2025.100509_bib0005","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2014-04-570010","article-title":"A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis","volume":"124","author":"Palladini","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lrr.2025.100509_bib0006","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004","volume":"79","author":"Gertz","year":"2005","journal-title":"Am. J. Hematol."},{"issue":"20","key":"10.1016\/j.lrr.2025.100509_bib0007","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood."},{"issue":"3","key":"10.1016\/j.lrr.2025.100509_bib0008","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41375-018-0370-z","article-title":"Comparative analysis of staging systems in AL amyloidosis","volume":"33","author":"Muchtar","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.lrr.2025.100509_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.643815","article-title":"The provocative roles of platelets in liver disease and cancer","volume":"11","author":"Kanikarla Marie","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lrr.2025.100509_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106454","article-title":"Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy","volume":"98","author":"Javorniczky","year":"2020","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.lrr.2025.100509_bib0011","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/jha2.713","article-title":"When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: lessons from mistakes","volume":"4","author":"Willekens","year":"2023","journal-title":"EJHaem"},{"issue":"3","key":"10.1016\/j.lrr.2025.100509_bib0012","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/bjh.13600","article-title":"Chronic neutrophilic leukaemia and plasma cell-related neutrophilic leukaemoid reactions","volume":"171","author":"Bain","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.lrr.2025.100509_bib0013","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/10428190290012218","article-title":"Coexistence of chronic neutrophilic leukemia with multiple myeloma","volume":"43","author":"Din\u00e7ol","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.lrr.2025.100509_bib0014","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/jha2.171","article-title":"Multiple myeloma with G-CSF production mimicking chronic neutrophilic leukemia","volume":"2","author":"Ureshino","year":"2021","journal-title":"EJHaem"},{"issue":"1","key":"10.1016\/j.lrr.2025.100509_bib0015","first-page":"72","article-title":"Mieloproliferativnye \u00abmaski\u00bb mnozhestvenno\u012d mielomy (obzor literatury i opisanie klinicheskikh nabliudeni\u012d) [Myeloproliferative masks of multiple myeloma: a review of literature and clinical case reports]","volume":"89","author":"Ryzhko","year":"2017","journal-title":"Ter. Arkh."},{"issue":"7","key":"10.1016\/j.lrr.2025.100509_bib0016","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100509_bib0017","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2017.06.010","article-title":"Inflammation and myeloproliferative neoplasms","volume":"85","author":"Lussana","year":"2017","journal-title":"J. Autoimmun."},{"issue":"11","key":"10.1016\/j.lrr.2025.100509_bib0018","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ajh.23295","article-title":"Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis","volume":"87","author":"Vaidya","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"9","key":"10.1016\/j.lrr.2025.100509_bib0019","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.3390\/ijms22094462","article-title":"The role of marrow microenvironment in the growth and development of malignant plasma cells in multiple myeloma","volume":"22","author":"Giannakoulas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.lrr.2025.100509_bib0020","first-page":"139","article-title":"An elevated systemic inflammation index is related to inferior response to pomalidomide and dexamethasone treatment in patients with relapsed and refractory multiple myeloma","volume":"27","author":"Mikulski","year":"2023","journal-title":"Contemp. Oncol. (Pozn)"},{"key":"10.1016\/j.lrr.2025.100509_bib0021","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/cyto.2001.0982","article-title":"Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data","volume":"16","author":"Lauta","year":"2001","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.lrr.2025.100509_bib0022","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/ejhf.1039","article-title":"Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis","volume":"20","author":"Siegismund","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.lrr.2025.100509_bib0023","first-page":"16","article-title":"Hepatic amyloidosis: a prevalence study and clinical characterization of a rare and severe disease","volume":"115","author":"Dias","year":"2023","journal-title":"Rev. Esp. Enferm. Dig."},{"issue":"25","key":"10.1016\/j.lrr.2025.100509_bib0024","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood.2019000834","article-title":"A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib","volume":"134","author":"Manwani","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.lrr.2025.100509_bib0025","doi-asserted-by":"crossref","unstructured":"L. Chacko, M. Boldrini, R. Martone, Law S., Martinez-Naharrro A., Hutt DF, Kotecha T., Patel RK, Razvi Y., Rezk T., Cohen OC, Brown JT, Srikantharajah M., Ganesananthan S., Lane T., Lachmann HJ, Wechalekar AD, Sachchithanantham S., Mahmood S., Whelan CJ, Knight DS, Moon JC, Kellman P., Gillmore JD, Hawkins PN, Fontana M.et al., Cardiac Magnetic resonance-derived extracellular volume mapping for the quantification of hepatic and splenic amyloid, Circ. Cardiovasc. Imaging Volume 14, Number 4, April 2021; doi: 10.1161\/CIRCIMAGING.121.012506. PMID: 33876651.","DOI":"10.1161\/CIRCIMAGING.121.012506"},{"issue":"2","key":"10.1016\/j.lrr.2025.100509_bib0026","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4322\/acr.2016.035","article-title":"Amyloidosis: an unusual cause of portal hypertension","volume":"6","author":"Takayasu","year":"2016","journal-title":"Autops. Case Rep."},{"issue":"52","key":"10.1016\/j.lrr.2025.100509_bib0027","doi-asserted-by":"crossref","first-page":"e5645","DOI":"10.1097\/MD.0000000000005645","article-title":"Primarily isolated hepatic involvement of amyloidosis: a case report and overview","volume":"95","author":"Ye","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.lrr.2025.100509_bib0028","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ajh.23154","article-title":"Hyposplenism: comparison of different methods for determining splenic function","volume":"87","author":"Lammers","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.lrr.2025.100509_bib0029","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1080\/07853890.2022.2069281","article-title":"The clinical features and outcomes of systemic light chain amyloidosis with hepatic involvement","volume":"54","author":"Zhao","year":"2022","journal-title":"Ann. Med."}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048925000111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:15:27Z","timestamp":1750180527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048925000111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":29,"alternative-id":["S2213048925000111"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100509","relation":{},"ISSN":["2213-0489"],"issn-type":[{"value":"2213-0489","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AL amyloidosis with elevated peripheral blood cell counts \u2013 A frequent association with liver involvement. A single-center retrospective study","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2025.100509","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100509"}}